Skip to main content
. 2020 Aug 10;112(6):1438–1447. doi: 10.1093/ajcn/nqaa207

FIGURE 1.

FIGURE 1

Metabolic pathway of intravenously administered choline and its methyl groups using deuterium-labeled methyl-D9-choline. Methyl groups labeled with deuterium are represented by the black dots; the unlabeled methyl groups are represented by the white dots. The methyl-D9-choline can enter the CDP-choline pathway (*) to produce D9-PC. Alternatively, it can be oxidized to D9-betaine, which then donates a single methyl group to homocysteine, producing D6-DMG and D3-methionine. D3-methionine serves as a precursor for D3-SAMe, which can be used by PEMT (‡) to sequentially methylate PE, forming D3-PC as well as smaller amounts of D6-PC. A fraction of D3-choline or D6-choline is released by hydrolysis of PEMT-derived D3-PC or D6-PC in the liver and recycled back to D3-PC or D6-PC by the CDP-choline pathway. CDP-choline, cytidine diphosphocholine; DMG, dimethylglycine; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PEMT, phosphatidylethanolamine N-methyltransferase; S-AdHo, S-adenosylhomocysteine; SAMe, S-adenosylmethionine.